Monsanto Co. (NYSE:MON) gapped up before the market opened on Wednesday . The stock had previously closed at $102.18, but opened at $102.88. Monsanto shares last traded at $104.57, with a volume of 3,536,310 shares trading hands.

MON has been the subject of several analyst reports. TheStreet lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Citigroup Inc. upped their price objective on Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research note on Friday, August 19th. BMO Capital Markets set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th. Credit Agricole SA lowered Monsanto from a “buy” rating to an “underperform” rating and set a $110.00 price objective for the company. in a research note on Thursday, September 15th. Finally, Deutsche Bank AG restated a “buy” rating and issued a $118.00 price objective on shares of Monsanto in a research note on Thursday, June 30th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Monsanto presently has an average rating of “Hold” and an average price target of $113.02.

The company has a 50-day moving average price of $105.82 and a 200 day moving average price of $100.43. The company has a market cap of $45.67 billion, a price-to-earnings ratio of 45.93 and a beta of 1.24.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/monsanto-co-mon-shares-gap-up-to-102-88.html

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 29th. The company reported $2.17 earnings per share for the quarter, missing analysts’ consensus estimates of $2.40 by $0.23. The business had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.49 billion. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The business’s revenue was down 8.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.39 earnings per share. On average, equities research analysts anticipate that Monsanto Co. will post $4.46 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.07%. Monsanto’s payout ratio is presently 89.26%.

In related news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. Corporate insiders own 0.88% of the company’s stock.

A number of institutional investors have recently bought and sold shares of MON. WFG Advisors LP raised its position in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the last quarter. Howard Hughes Medical Institute acquired a new position in Monsanto during the first quarter worth $110,000. Signaturefd LLC raised its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC raised its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the last quarter. Finally, Pinkerton Retirement Specialists LLC raised its position in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the last quarter. Hedge funds and other institutional investors own 79.06% of the company’s stock.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.